NRM CLIA-411 Supports TK1 for Early Tumor Diagnosis

NRM CLIA-411 Supports TK1 for Early Tumor Diagnosis

Norman Fully Automatic Chemiluminescence CLIA 411 now supports TK1 (Thymidine kinase 1), a marker especially for early diagnosis and prognosis of tumor or cancer diseases. 


Thymidine Kinase 1 (TK1) is a key enzyme in DNA precursor synthesis. It is upregulated during the late G1 phase and early S phase of the cell cycle and its presence in cells is an indicator of active cell proliferation. Increased levels of TK1 in the blood can indicate active cell proliferation as a consequence of abnormal cell turnover and cell disruption triggered by for example therapeutic agents.

Please feel free to give your inquiry in the form below. We will reply you in 24 hours.